Literature DB >> 3379138

Human chorionic gonadotropin stimulates iodide uptake, adenylate cyclase, and deoxyribonucleic acid synthesis in cultured rat thyroid cells.

J M Hershman1, H Y Lee, M Sugawara, C J Mirell, X P Pang, M Yanagisawa, A E Pekary.   

Abstract

hCG stimulates thyroid function, but it has been suggested that it is impurities in commercial hCG preparations or a variant of hCG that are responsible for the thyrotropic activity. In this study, we tested the thyrotropic activity of purified and commercial hCG and compared its action with that of bovine TSH (bTSH) in cultured rat FRTL-5 cells in regard to stimulation of iodide uptake, activation of adenylate cyclase, and synthesis of DNA. Iodide uptake was measured after incubation of the cells for 48-72 h with the test hormones, followed by a 40-min incubation with 0.1 microCi Na125I and 10 mumol/L carrier NaI; the 125I in the washed cells was counted. Adenylate cyclase was measured after incubation of the cells with the test stimulators for 3 h in hypotonic medium by RIA of cAMP in the medium. DNA synthesis was measured after incubation of the cells with the test substances for 24 h, followed by addition of [3H]thymidine for 3 h and then measuring the incorporation of [3H]thymidine into the cells. Both purified and commercial hCG produced a dose-related increase in iodide uptake. The relative potency of commercial hCG was 0.024 microU bTSH/U hCG and that of purified hCG was 0.042 microU bTSH/U hCG; compared with human TSH, the potency of purified hCG was 0.72 microU/U hCG. hCG caused a dose-related increment of adenylate cyclase and [3H]thymidine incorporation. The effect of hCG on iodide uptake and [3H]thymidine incorporation was additive with that of bTSH; hCG was not an antagonist of TSH in these cultured rat thyroid cells. We conclude that hCG has intrinsic thyrotropic activity in FRTL-5 cells in regard to stimulation of iodide uptake, activation of adenylate cyclase, and stimulation of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379138     DOI: 10.1210/jcem-67-1-74

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Bromocriptine reduces rat thyrotropin beta-subunit mRNA stability.

Authors:  A Levy; S L Lightman
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

Review 2.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 3.  Thyroid stimulation by placental factors.

Authors:  K Mann; R Hoermann
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

4.  Thromboblastic hyperthyroidism: sensitive monoclonal TSH assay demonstrates suppressed immunoreactive TSH.

Authors:  B Abuaisha; E Barrett; J O'Hare
Journal:  Ir J Med Sci       Date:  1991-03       Impact factor: 1.568

5.  Thyrotropin binding specificity for the thyrotropin receptor.

Authors:  Y Nagayama; H Yamasaki; A Takeshita; H Kimura; K Ashizawa; N Yokoyama; S Yamashita; B Rapoport; S Nagataki
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

6.  The relationship between LH and thyroid volume in patients with PCOS.

Authors:  Evrim Cakir; Mustafa Sahin; Oya Topaloglu; Nujen Bozkurt Colak; Basak Karbek; Askin Gungunes; Muyesser Sayki Arslan; Ilknur Ozturk Unsal; Esra Tutal; Bekir Ucan; Tuncay Delibasi
Journal:  J Ovarian Res       Date:  2012-12-11       Impact factor: 4.234

7.  Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease.

Authors:  L Walkington; J Webster; B W Hancock; J Everard; R E Coleman
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

8.  Medical hypothesis: can gonadotropins influence thyroid volume in women with PCOS?

Authors:  Evrim Cakir; Mustafa Sahin; Erman Cakal; Mustafa Ozbek; Tuncay Delibasi
Journal:  Thyroid Res       Date:  2012-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.